http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007524421-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2005-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007524421-A |
| titleOfInvention | Detection of human papillomavirus |
| abstract | The present invention is a method for in vitro screening of human subjects in the presence of human papillomavirus (HPV), wherein the HPV exhibits loss of regulation of E6 / E7 mRNA expression and loss of replication, and / or full-length E6 protein The present invention relates to the above-mentioned method, which shows the expression of a stabilized mRNA precursor encoding In particular, the present invention provides in vitro screening methods for persistent cellular abnormalities or persistent CIN III lesions, carcinoma in situ or high grade squamous intraepithelial lesions (HSIL). The method is useful in screening for cervical cancer. |
| priorityDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 318.